List of Medicines for Brand Consideration reference set

This reference set supports the identification of Australian Medicines Terminology (AMT) Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.

Under the National Health (Pharmaceutical Benefits) Regulations 2017, the Repatriation Pharmaceutical Benefits Scheme Instrument 2013 and MRCA Pharmaceutical Benefits Scheme Instrument 2013, all Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary.

This reference set can be used by prescribing-software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.